Kurt Knoll, PA
Physician Assistant · Murfreesboro, TNNPI 1518951656
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,001 of the $13,133 with a category attached, or 60.9%. 38 manufacturers reported payments, led by Pfizer at 45.9% of the total. 2025 is the largest year on record at $6,004, 6.2 times the $965 reported in 2021. Among physician assistant clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 417 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- AbbVie$1K
- Novo Nordisk$692
- Biohaven Pharmaceutical Holding Company Ltd.$684
- Otsuka America Pharmaceutical, Inc.$603
- Lilly USA, LLC$589
- plus $3K from 32 others
What the payments were for
- Consulting fees$4,00530%
- Travel & lodging$1,0828%
- Food & beverage$8,00161%
- Education$450%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZAVZPRET$4,005
- NURTEC ODT$301
How this compares
$13,133 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $52,995 |
| OzempicSemaglutide | 24 | $30,803 |
| JanuviaSitagliptin Phosphate | 14 | $17,305 |
| KerendiaFinerenone | 21 | $16,776 |
| JardianceEmpagliflozin | 18 | $16,497 |
| XareltoRivaroxaban | 27 | $15,402 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $13,244 |
| FarxigaDapagliflozin Propanediol | 19 | $10,381 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $5,066 |
| PremarinEstrogens, Conjugated | 12 | $4,684 |
| Tolterodine Tartrate ErTolterodine Tartrate | 13 | $3,236 |
| Testosterone | 15 | $2,310 |
| Novolog FlexpenInsulin Aspart | 13 | $1,914 |
| Rosuvastatin Calcium | 118 | $1,640 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $1,567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $589 | $52,99544 claims |
| Novo NordiskOzempic | $692 | $30,80324 claims |
| MerckJanuvia | $53 | $17,30514 claims |
| BayerKerendia | $137 | $16,77621 claims |
| Boehringer IngelheimJardiance | $51 | $16,49718 claims |
| AstraZenecaFarxiga | $146 | $10,38119 claims |
| PfizerPremarin | $6,031 | $4,68412 claims |
| AbbVieSynthroid | $1,436 | $1,26816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Murfreesboro
- Joseph AyersMurfreesboro$73K
- Ruchi PatelMurfreesboro$23K
- Bailey ChitwoodMurfreesboro$22K
- Taylor NewmanMurfreesboro$16K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$187K
- Katherine RunyanKnoxville$156K
- Robert LaughertyAlcoa$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.